Home › Funds › ACT Capital Partners, L.P. › TGTX
ACT Capital Partners, L.P. position in TGTX
TG THERAPEUTICS · Health Care
ACT Capital Partners, L.P. reported holding 237,200 shares of TGTX (TG THERAPEUTICS) in its Q3 2026 13F filing — a position valued at US$13.2M, representing 8.98% of its reported portfolio and ranking #3 among its reported holdings. ACT Capital Partners, L.P. first reported this position in Q3 2026.
Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR
How ACT Capital Partners, L.P.'s TGTX position evolved
ACT Capital Partners, L.P. first disclosed a stake in TGTX in Q3 2026 at 237,200 shares (US$13.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 237.20K | $13.23M | New |
About TGTX and 13F data
TGTX (TG THERAPEUTICS) is a Health Care company. 53 other funds we track also report a position in TGTX — the largest reported positions include Soleus Capital Management, L.P. (US$160.9M), CONGRESS ASSET MANAGEMENT CO (US$145.4M), Penn Capital Management Company, LLC (US$29.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TGTX
- Soleus Capital Management, L.P. 2.93M sh · $160.86M · Q2 2026
- CONGRESS ASSET MANAGEMENT CO 2.61M sh · $145.39M · Q3 2026
- Penn Capital Management Company, LLC 536.07K sh · $29.51M · Q2 2026
- Opaleye Management Inc. 535.00K sh · $29.39M · Q2 2026
- Occam Crest Management LP 425.00K sh · $22.73M · Q2 2026
- 683 Capital Management, LLC 389.08K sh · $21.38M · Q2 2026
More on ACT Capital Partners, L.P.
FAQ
How long has ACT Capital Partners, L.P. held TGTX?
ACT Capital Partners, L.P. has disclosed TGTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ACT Capital Partners, L.P.'s current position in TGTX?
As of Q3 2026, ACT Capital Partners, L.P. holds 237.20K shares of TGTX (TG THERAPEUTICS), valued at $13.23M, representing 8.98% of its reported portfolio and ranking #3.
Has ACT Capital Partners, L.P. been buying or selling TGTX?
In the latest 13F filing (Q3 2026), ACT Capital Partners, L.P. newly opened its position in TGTX.
Which other funds hold TGTX?
Other major institutional holders of TGTX include Soleus Capital Management, L.P., CONGRESS ASSET MANAGEMENT CO, Penn Capital Management Company, LLC, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.